This page shows the latest UK Health Security Agency news and features for those working in and with pharma, biotech and healthcare.
The World Health Organization (WHO) has reported that the BA.2 subvariant of Omicron coronavirus does not appear to be worse or any more severe than its original form, BA.1. ... Speaking on behalf of the UK’s pandemic response in light of the emerging
Current data from the UK has shown that both Pfizer and Moderna’s vaccines are only around 10% effective at preventing symptomatic infection from the Omicron variant 20 weeks after receiving ... The data comes from a study by the UK Health Security
The change of policy comes after results from the first real-world study on the effectiveness of the booster jabs were published by the UK Health Security Agency (UKHSA). ... Uptake of COVID-19 vaccines in the UK is relatively high, with just under 88%
The NVAP was developed by PHE in April 2021 and will be advanced by the new UK Health Security Agency (UKHSA). ... The new UK Health Security Agency (UKHSA) will work to protect against future health threats and will take over the COVID-19 pandemic
The UK Health Security Agency will protect against future health threats. ... The UK Health Security Agency (UKHSA) will protect against future health threats, and will take over the COVID-19 pandemic response from Public Health England (PHE) and NHS
More from news
Approximately 2 fully matching, plus 3 partially matching documents found.
We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...